Skip to content
Shionogi
-
Shionogi increases stake in ViiV Healthcare as Pfizer exits HIV venture in USD2.13B deal
The transaction marks the end of Pfizer’s involvement with ViiV Healthcare, as the American pharmaceutical giant sells its entire 11.7% stake in the company.